Edo Banach advises healthcare providers, health plans, industry stakeholders, and healthcare innovators on matters where government policy and business strategy converge. He represents clients in disputes involving Medicare and Medicaid reimbursement, coverage determinations, regulatory requirements, and federal healthcare programs, often when significant operational, financial, and strategic interests are on the line.
As partner and co-chair of Foley Hoag's Healthcare Department, Edo counsels organizations across the healthcare continuum on issues involving Medicare Advantage, Medicaid managed care, Medicare-Medicaid integration, value-based care, long-term services and supports, home and community-based services, and innovative care delivery models. He works closely with providers serving aging, seriously ill, and medically complex populations through post-acute, home-based, palliative care, hospice, and long-term care programs. His practice spans regulatory compliance, administrative appeals, government relations, healthcare fraud and abuse matters, and advocacy before federal and state agencies.
Edo's perspective reflects experience across nearly every level of the healthcare system. Before entering private practice, he served as Deputy Director of the Centers for Medicare & Medicaid Services' (CMS) Medicare-Medicaid Coordination Office, where he helped lead federal efforts to improve coordination and care delivery for Medicare-Medicaid beneficiaries through integrated care and dual-eligible initiatives. He later served as President and Chief Executive Officer of the National Hospice and Palliative Care Organization (NHPCO), leading nationwide advocacy efforts before CMS, the Department of Health and Human Services (HHS), Congress, and the White House on issues affecting providers, patients, and the delivery of serious illness and end-of-life care.
Drawing on these experiences, Edo helps clients navigate matters that frequently sit at the center of broader policy debates. He advises organizations confronting significant reimbursement and coverage disputes, responding to regulatory change, and evaluating the business implications of government action. He also works with healthcare innovators developing integrated, value-based, and community-based care models, helping them navigate the regulatory and policy issues that accompany new approaches to care delivery.
Having worked inside government, led industry advocacy efforts, and advised clients in private practice, Edo brings a practical understanding of how healthcare policy is developed, implemented, interpreted, and enforced. His experience engaging with CMS, HHS, congressional offices, industry associations, and healthcare stakeholders enables him to help clients anticipate policy developments, advance legislative and regulatory priorities, and develop strategies that align legal, operational, and business objectives.
Edo advises clients on a broad range of Medicare, Medicaid, and healthcare regulatory matters, including Medicare Advantage, Medicaid managed care, dual-eligible integration initiatives, Special Needs Plans (SNPs), Programs of All-Inclusive Care for the Elderly (PACE), value-based care arrangements, long-term services and supports (LTSS), home and community-based services (HCBS), post-acute care, hospice and palliative care, healthcare compliance, HIPAA, privacy and consent requirements, healthcare fraud and abuse issues, administrative appeals, reimbursement and coverage disputes, and interactions with CMS and other federal and state regulators.
He regularly represents providers, health systems, managed care organizations, accountable care organizations, post-acute care providers, hospice and palliative care organizations, healthcare technology companies, and other healthcare stakeholders navigating complex federal and state healthcare requirements. His practice also includes healthcare policy advocacy and strategic counseling related to legislation, rulemaking, reimbursement policy, integrated care delivery, care model innovation, and government relations before Congress, HHS, CMS, and state agencies.